vt3989
vivace therapeutics,vivace therapeutics
['vt3989 i', 'mesothelioma', 'vt3989']
the hippo-yap-tead pathway is druggable! impressive activity from first in class first in human phase 1 trial of yap inhibitor vt3989 in mesothelioma and nf2 alterations! case a young patient with pericardial mesothelioma came off oxygen with therapy! #aacr23 #targetedtherapy 
Incoming @ The Angeles Clinic and Research Institute Cedars Sinai affiliate with phase 1 interesr. Frmr phase 1 fellow at MD Anderson & faculty UCI. KU Alum.